Literature DB >> 11333097

Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.

K Chijiiwa1, K Nakano, J Ueda, H Noshiro, E Nagai, K Yamaguchi, M Tanaka.   

Abstract

BACKGROUND: Because T2 carcinoma of the gallbladder that invades perimuscular connective tissue without extension beyond serosa or into the liver has a hope for longterm survival, we attempted to clarify significant prognostic factors with respect to tumor- and surgery-related variables. STUDY
DESIGN: Of 65 patients with gallbladder carcinoma who had undergone surgical resection from 1983 to 1999, 28 had T2 carcinoma histologically proved. The significance of variables for survival was examined by the Kaplan-Meier method and log-rank test followed by multivariate analyses using Cox's proportional hazard model.
RESULTS: There were 17 patients with stage II carcinoma (T2 N0 M0), 6 with stage III (T2 N1 M0), and 5 with stage IVB. Lymph node metastasis was present in 11 patients (39%) and it reached to the peripancreatic head region (N2) in 5 of them. Lymphatic, venous, and perineural invasions were found in 68%, 57%, and 43%, respectively. With respect to tumor factors, the absence of perineural invasion (Odds ratio [OR] 16.77, 95% confidence interval [CI] 2.17-129.94, p = 0.0069), absence of lymph node metastasis (OR 15.00, 95% CI 2.08-108.33, p = 0.0073), and stage II (II versus III and IVB, OR 15.00, 95% CI 2.08-108.33, p = 0.0073) were significant factors related to good postoperative survival in the multivariate analysis. Surgical procedure (radical resection versus cholecystectomy, OR 4.31, 95% CI 1.34-13.82, p = 0.0142) and surgical margin (OR 7.41, 95% CI 2.19-25.13, p = 0.0013) were significant factors in the univariate analysis. Cancer-free surgical margins provided a significantly better survival (5-year survival rate, 62%); none with cancer-positive surgical margins survived for more than 27 months. In the multivariate analysis, surgical procedure was significant (OR 25.49, 95% CI 1.62-400.72, p = 0.021). Radical surgery, including extended cholecystectomy (resection of the gallbladder together with the gallbladder bed of the liver) and anatomic resection of liver segment 5 and of the lower part of segment 4, gave a significantly better 5-year survival rate than cholecystectomy (59% versus 17%). The 5-year survival rate after radical resection in patients with stage II was 75%; that in patients with stage III and IVB was 33%.
CONCLUSIONS: Results suggest that radical surgery is the treatment of choice for patients with T2 carcinoma of the gallbladder. The presence of lymph node metastasis, perineural invasion, or both suggests the necessity of additional treatment after radical surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333097     DOI: 10.1016/s1072-7515(01)00814-6

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  62 in total

1.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Comparative analysis between clinical outcomes of primary radical resection and second completion radical resection for T2 gallbladder cancer: single-center experience.

Authors:  Seong Yeon Cho; Sang-Jae Park; Seong Hoon Kim; Sung-Sik Han; Young-Kyu Kim; Kwang-Woong Lee
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature.

Authors:  Seok L Ong; Giuseppe Garcea; Sarah C Thomasset; Christopher P Neal; David M Lloyd; David P Berry; Ashley R Dennison
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Lymphatic invasion: an important prognostic factor for stages T1b-T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer.

Authors:  Kohei Shibata; Hiroki Uchida; Kentaro Iwaki; Seiichiro Kai; Masayuki Ohta; Seigo Kitano
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

Review 5.  Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review.

Authors:  Hilko A Swank; Irene M Mulder; Wim C Hop; Marc J van de Vijver; Johan F Lange; Willem A Bemelman
Journal:  Surg Endosc       Date:  2013-07-23       Impact factor: 4.584

6.  Does laparoscopy worsen the prognosis for incidental gallbladder cancer?

Authors:  T Goetze; V Paolucci
Journal:  Surg Endosc       Date:  2005-12-09       Impact factor: 4.584

7.  Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.

Authors:  Sung-Chan Gwark; Shin Hwang; Ki-Hun Kim; Yong-Joo Lee; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

8.  Gadoxetic acid-enhanced MRI for T-staging of gallbladder carcinoma: emphasis on liver invasion.

Authors:  J Hwang; Y K Kim; D Choi; H Rhim; W J Lee; S S Hong; H-J Kim; Y-W Chang
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

Review 9.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

10.  Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.

Authors:  Abhay K Kattepur; Shraddha Patkar; Mahesh Goel; Anant Ramaswamy; Vikas Ostwal
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.